Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02590159 · ClinicalTrials.gov registry record · NA
Clinical Study for the BONGO NASAL Expiratory Positive Airway Pressure (EPAP) Device in the Treatment of Obstructive Sleep Apnea (OSA)
A NA study, sponsored by InnoMed Healthscience.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02590159 is a NA study that was terminated before completion, run by InnoMed Healthscience. The registered enrollment target is 9 participants.
The verdict
NCT02590159, a NA study, was terminated before completion, sponsored by InnoMed Healthscience.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Single center clinical study for the BONGO NASAL EPAP device in the treatment of obstructive sleep apnea for the purpose of obtaining safety and efficacy data
Interventions
- DEVICE BONGO NASAL EPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02590159
The ClinicalTrials.gov registry entry for NCT02590159 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InnoMed Healthscience, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BONGO NASAL EPAP is the first listed.
NCT02590159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02590159 about?
NCT02590159 is a clinical study titled "Clinical Study for the BONGO NASAL Expiratory Positive Airway Pressure (EPAP) Device in the Treatment of Obstructive Sleep Apnea (OSA)". Single center clinical study for the BONGO NASAL EPAP device in the treatment of obstructive sleep apnea for the purpose of obtaining safety and efficacy data
What is the current status of trial NCT02590159?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2015-11. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02590159?
The interventions under investigation include: BONGO NASAL EPAP (DEVICE).
Who is sponsoring clinical trial NCT02590159?
This trial is sponsored by InnoMed Healthscience, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.